Allene M. Diaz's most recent trade in Ionis Pharmaceuticals Inc was a trade of 4,079 Restricted Stock Unit done . Disclosure was reported to the exchange on July 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ionis Pharmaceuticals Inc | Allene M. Diaz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2025 | 4,079 | 5,220 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | Allene M. Diaz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2025 | 4,079 | 19,795 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Allene M. Diaz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 11,518 | 11,518 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharmaceuticals Inc | Allene M. Diaz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 5,220 | 9,299 | - | - | Restricted Stock Unit | |
| Mersana Therapeutics Inc | Allene M. Diaz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 61,500 | 61,500 | - | - | Stock Option (right to buy) | |
| Ionis Pharmaceuticals Inc | Allene M. Diaz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2024 | 4,677 | 4,079 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | Allene M. Diaz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2024 | 4,677 | 17,353 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Allene M. Diaz | Director | Sale of securities on an exchange or to another person at price $ 48.94 per share. | 15 Jul 2024 | 900 | 16,453 (0%) | 0% | 48.9 | 44,044 | Common Stock |
| Ionis Pharmaceuticals Inc | Allene M. Diaz | Director | Sale of securities on an exchange or to another person at price $ 50.17 per share. | 15 Jul 2024 | 737 | 15,716 (0%) | 0% | 50.2 | 36,975 | Common Stock |
| Ionis Pharmaceuticals Inc | Allene M. Diaz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 10,111 | 10,111 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharmaceuticals Inc | Allene M. Diaz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 4,079 | 8,756 | - | - | Restricted Stock Unit | |
| Mersana Therapeutics Inc | Allene M. Diaz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
| Ionis Pharmaceuticals Inc | Allene M. Diaz | Director | Sale of securities on an exchange or to another person at price $ 41.05 per share. | 01 Aug 2023 | 657 | 12,676 (0%) | 0% | 41.1 | 26,970 | Common Stock |
| Ionis Pharmaceuticals Inc | Allene M. Diaz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2023 | 5,333 | 13,333 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Allene M. Diaz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2023 | 5,333 | 4,677 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | Allene M. Diaz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 10,321 | 10,321 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharmaceuticals Inc | Allene M. Diaz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 4,677 | 10,010 | - | - | Restricted Stock Unit | |
| Mersana Therapeutics Inc | Allene M. Diaz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 18,355 | 18,355 | - | - | Stock Option (right to buy) | |
| Mersana Therapeutics Inc | Allene M. Diaz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 14,467 | 14,467 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Allene M. Diaz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 8,000 | 8,000 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Allene M. Diaz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 8,000 | 5,333 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | Allene M. Diaz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 12,000 | 12,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharmaceuticals Inc | Allene M. Diaz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 5,333 | 13,333 | - | - | Restricted Stock Unit | |
| Mersana Therapeutics Inc | Allene M. Diaz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Mersana Therapeutics Inc | Allene M. Diaz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 10,416 | 10,416 | - | - | Stock Option (right to buy) |